United States · FDA National Drug Code directory
Clindamycin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-7374_dd1ccf51-13d4-446f-8a8b-c3685d040508
- Product NDC
- 50090-7374
- Form
- CAPSULE
- Composition / generic term
- Clindamycin Hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230310
- Source listing expiry
- 20271231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (50090-7374-0) · 50090-7374-0
- 15 CAPSULE in 1 BOTTLE (50090-7374-1) · 50090-7374-1
- 4 CAPSULE in 1 BOTTLE (50090-7374-3) · 50090-7374-3
- 100 CAPSULE in 1 BOTTLE (50090-7374-4) · 50090-7374-4
- 21 CAPSULE in 1 BOTTLE (50090-7374-6) · 50090-7374-6
- 42 CAPSULE in 1 BOTTLE (50090-7374-7) · 50090-7374-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →